The depression drugs market, which was estimated to be worth over US$ 6.5 billion in 2017, is expected to see bearishness soon. A recent Fact.MR analysis estimated that revenues would drop at a CAGR of -2%. The study indicates that even if the incidence of depression prevalence has increased over the past ten years, there has been a decrease in the demand for depression drugs due to people's...